BridgeBio Oncology

BBOT

Börsenwert 205 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
51	51 Squarepoint New York	149.824 $	-196.391 $	-23.528	-54 %
52	52 Vanguard Global Advisers Malvern, Pennsylvania	138.402 $	–	–	–
53	53 Schonfeld Strategic Advisors New York	87.659 $	+96.025 $	+11.504	Neu
54	54 Profund Advisors Bethesda, Maryland	83.828 $	+91.826 $	+11.001	Neu
55	55 AXQ Capital Jersey City, New Jersey	81.747 $	-55.249 $	-6.619	-38 %
56	56 Morgan Stanley New York	25.755 $	-333.834 $	-39.994	-92 %
57	57 Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong	20.115 $	+21.919 $	+2.626	Neu
58	58 Barclays London, United Kingdom	15.995 $	+15.751 $	+1.887	+890 %
59	59 Tower Research Capital (TRC) New York	12.924 $	+14.157 $	+1.696	Neu
60	60 Northwestern Mutual Wealth Management Milwaukee, Wisconsin	10.287 $	+11.269 $	+1.350	Neu
61	61 Rockefeller Capital Management New York	7.620 $	+2.504 $	+300	+43 %
62	62 Pacer Advisors Malvern, Pennsylvania	3.000 $	+3.155 $	+378	Neu
63	63 Wells Fargo San Francisco, California	2.286 $	–	–	–
64	64 Quarry LP New York	1.501 $	+1.644 $	+197	Neu
65	65 Caitong International Asset Management Hong Kong	282 $	+275 $	+33	+825 %
66	66 Paradigm Biocapital Advisors New York	–	-7,77 Mio. $	-868.213	Geschlossen
67	67 Octagon Capital Advisors New York	–	-6,44 Mio. $	-719.000	Geschlossen
68	68 Eventide Asset Management Boston, Massachusetts	–	-4,7 Mio. $	-541.181	Geschlossen
69	69 Ikarian Capital Dallas, Texas	–	-2,42 Mio. $	-270.231	Geschlossen
70	70 Hudson Bay Capital Management Stamford, Connecticut	–	-984.500 $	-110.000	Geschlossen
71	71 Woodline Partners San Francisco, California	–	-928.178 $	-103.707	Geschlossen
72	72 Boothbay Fund Management New York	–	-723.912 $	-80.884	Geschlossen
73	73 HighVista Strategies Boston, Massachusetts	–	-699.774 $	-78.187	Geschlossen
74	74 Qube Research & Technologies (QRT) London, United Kingdom	–	-643.729 $	-71.925	Geschlossen
75	75 XTX Topco George Town, Cayman Islands	–	-534.700 $	-59.743	Geschlossen

BridgeBio Oncology BBOT Börsenwert 205 Mio. $

BridgeBio Oncology

BBOT

Börsenwert 205 Mio. $